Barclays »

Apellis Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $12M 196k 59.86
2023-09-30 $23M 599k 38.04
2023-06-30 $28M 312k 91.10
2023-03-31 $16M 242k 65.96
2022-12-31 $12M 227k 51.71
2022-09-30 $9.1M 133k 68.31
2022-06-30 $1.1M 23k 45.22
2022-03-31 $2.7M 53k 50.79
2021-12-31 $6.9M 145k 47.27
2021-09-30 $1.2M 36k 32.98
2021-06-30 $2.3M 37k 63.21
2021-03-31 $3.9M 92k 42.92
2020-12-31 $5.1M 89k 57.20
2020-09-30 $4.9M 161k 30.17
2020-06-30 $2.1M 64k 32.66
2020-03-31 $5.1M 190k 26.78
2019-12-31 $36M 1.2M 30.62
2019-09-30 $1.1M 47k 24.11
2019-06-30 $4.9M 194k 25.34
2019-03-31 $3.0M 154k 19.50
2018-12-31 $21k 1.6k 13.28
2018-09-30 $251k 14k 17.83
2018-06-30 $58k 2.6k 21.90
2018-03-31 $53k 2.4k 22.39
2017-12-31 $37k 1.7k 21.55